About Brio Pharma Technologies Private Limited
Data last updated:
Brio Pharma Technologies Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the industrial products retail and distribution segment of the machinery and industrial equipment sector. It was incorporated on 10 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51496MH2005PTC157234. Its GSTIN is 27AACCB7462L2ZB (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Deelish Narayanan Kapadan and Deepak Virbhadra Kabbur.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.96 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net loss of ₹12.55 Lakh (net margin -1.3%) and EBITDA of ₹40.62 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 119% over three years and 38% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Brio Pharma Technologies.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website briopharmatech.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressOffice No. A – 705 & 706 Arihant Aura, Plot No.13/1 Ttc Industrial Area Turbhe MIDC, Thane, Maharashtra, India – 400703
- IndustryMachinery and Equipment, Industrial Products Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Brio Pharma Technologies Private Limited
Brio Pharma Technologies operates one associated brand: Brio Pharma Technologies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provision of technology solutions for pharmaceutical processing and packaging. | briopharmatech.com |
Business Activity of Brio Pharma Technologies Private Limited
The main business activity of Brio Pharma Technologies is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Brio Pharma Technologies Private Limited
Brio Pharma Technologies Private Limited is audited by MEHUL GOSAR & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MEHUL GOSAR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Brio Pharma Technologies Private Limited
Brio Pharma Technologies has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deelish Narayanan Kapadan Also directs: Brio Engineering Private Limited | Director | 31 Jan 2018 | 8 Years 8 Months | Current |
| Deepak Virbhadra Kabbur Also directs: Ibc Pharmaceuticals Private Limited, Brio Packaging Private Limited, Promedica Pharmaceuticals Private Limited and 1 more | Director | 11 Aug 2021 | 5 Years 1 Months | Current |
| Mithila Shubham Mishra | Director | 11 Aug 2021 | 5 Years 1 Months | Current |
| Shubham Suresh Mishra Also directs: S2 Genesis LLP, Ibc Pharmaceuticals Private Limited, Petals Packtech Private Limited and 4 more | Director | 10 Nov 2005 | 20 Years 10 Months | Current |
Financials of Brio Pharma Technologies Private Limited FY 2024 filings available
Brio Pharma Technologies Private Limited reported revenue of ₹9.96 Cr (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Brio Pharma Technologies Private Limited
Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Brio Pharma Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹40.62 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹12.55 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Brio Pharma Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Brio Pharma Technologies are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Brio Pharma Technologies Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Brio Pharma Technologies Private Limited
Brio Pharma Technologies Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Brio Pharma Technologies Private Limited
Brio Pharma Technologies Private Limited has a workforce of 9 employees as of Mar 23, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Brio Pharma Technologies Private Limited
Brio Pharma Technologies has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCB7462L2ZB | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Brio Pharma Technologies Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Brio Pharma Technologies Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Brio Pharma Technologies Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Brio Pharma Technologies Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Brio Pharma Technologies Private Limited
Frequently Asked Questions about Brio Pharma Technologies Private Limited
Brio Pharma Technologies is an active private limited company based in Thane, Maharashtra, India. The company works in industrial products retail and distribution, within the machinery and equipment industry. It was incorporated on 10 November 2005 (21+ years old) and is registered under CIN U51496MH2005PTC157234.
Brio Pharma Technologies reported revenue of ₹9.96 Cr for FY 2025 (down 13% YoY).
Brio Pharma Technologies has 4 current directors:
- Deelish Narayanan Kapadan - Director
- Deepak Virbhadra Kabbur - Director
- Mithila Shubham Mishra - Director
- Shubham Suresh Mishra - Director
Brio Pharma Technologies reported a net loss of ₹12.55 Lakh (net margin -1.3%) and EBITDA of ₹40.62 Lakh (EBITDA margin 4.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Brio Pharma Technologies is 119% over three years and 38% over five years. In the latest year (FY 2025) revenue fell 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Brio Pharma Technologies is 27AACCB7462L2ZB, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Brio Pharma Technologies is U51496MH2005PTC157234. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brio Pharma Technologies was incorporated on 10 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Brio Pharma Technologies can be reached through the website briopharmatech.com. Its registered office is in Thane, Maharashtra, India.